Furthermore, defects in DNA repair and damage response genes such as RAD51, KU80 SIRT1, NFAT5, and REV3L [47], or ESCC tumor cells expressed higher CLDN4 to harbor stem-like properties [48] are also the potential CCRT resistance mechanisms. This evidence concerns the gene REV3L and neoplasm.